Search

Search results

203 results found

Thrombospondin 1 and its mimetic peptide ABT-510 decrease angiogenesis and inflammation in a murine model of inflammatory bowel disease.

Punekar, Salman, Samantha Zak, Valerie G Kalter, Larissa Dobransky, Imran Punekar, Jack W Lawler, and Linda S Gutierrez. 2008. “Thrombospondin 1 and Its Mimetic Peptide ABT-510 Decrease Angiogenesis and Inflammation in a Murine Model of Inflammatory Bowel Disease.”. Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology 75 (1): 9-21.

Antiangiogenic treatment with the three thrombospondin-1 type 1 repeats recombinant protein in an orthotopic human pancreatic cancer model.

Zhang, Xuefeng, Eric Galardi, Mark Duquette, Marko Delic, Jack Lawler, and Sareh Parangi. 2005. “Antiangiogenic Treatment With the Three Thrombospondin-1 Type 1 Repeats Recombinant Protein in an Orthotopic Human Pancreatic Cancer Model.”. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 11 (6): 2337-44.

Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells with BRAF(V600E): New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment.